Atlas Trials

Long-term Safety and Tolerability of TRI476 (Oxcarbazepine) in Children With Inadequately Controlled Partial Onset Seizures

Clinical trial NCT01051193 · COMPLETED

Trial details

NCT number
NCT01051193
Sponsor
Nobelpharma
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Partial Onset Seizures
Start date
2010-01-05
Primary completion
2019-09-30
Enrollment
88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.